<DOC>
	<DOCNO>NCT00007930</DOCNO>
	<brief_summary>RATIONALE : Surgery remove tumor may effective treatment rectal cancer . It yet know whether one type surgery effective another rectal cancer . PURPOSE : Randomized phase III trial compare effectiveness two type surgery treating patient rectal cancer .</brief_summary>
	<brief_title>Comparison Two Types Surgery Treating Patients With Rectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare local distant recurrence patient mid-rectal cancer treat wide mesorectal surgical excision straight colorectal anastomosis versus total mesorectal surgical excision colonic J pouch coloanal anastomosis . - Compare functional , physiological , anatomical outcome patient treat two surgical procedure . - Compare disease-free survival overall survival patient treat two surgical procedure . OUTLINE : This randomize , multicenter study . Patients stratify accord treatment center . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo surgical resection wide mesorectal excision follow straight colorectal anastomosis . - Arm II : Patients undergo surgical resection total mesorectal excision follow colonic J pouch coloanal anastomosis . Patients receive temporary ileostomy close 6 week later . Patients follow 6 week , every 4-6 month 2 year , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : A minimum 800 patient ( 400 per arm ) accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Clinical diagnosis rectal cancer colonoscopy barium enema Distal margin tumor arises within 915 cm anal verge measure rigid sigmoidoscopy No synchronous multiple adenocarcinomas Candidate low anterior surgical resection laparoscopy conventional open method No evidence gross metastatic disease No evidence peritoneal pelvic metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : At least 6 month Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No malignancy within past 5 year PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Neoadjuvant adjuvant chemoradiotherapy allow Endocrine therapy : Not specify Radiotherapy : See Chemotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
</DOC>